Breast Cancer: Belsy's Survivor Story

Patient Info: Belsy, Female, 40s

Belsy was declared cancer-free in March 2023 after breast-conserving surgery/lumpectomy, chemotherapy, and radiation therapy, with no significant treatment side effects described.

Our Cancer StoriesRead more →

Stage II Breast Cancer: CL's Survivor Story

Patient Info: CL, Female, 50s | Stage II

CL completed chemotherapy and mastectomy for Stage II breast cancer, was no longer taking medication, and continued half-year follow-up with her doctor.

Our Cancer StoriesRead more →

Stage I Breast Cancer: Clara's Survivor Story

Patient Info: Clara, Female, 40s | Stage I

Clara completed treatment for Stage I breast cancer and focused afterward on nutrition, relapse prevention, staying healthy, and returning to family life.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Claritza's Patient Story

Patient Info: Claritza, Female, 50s | Stage III

Claritza was living with Stage III breast cancer more than 3 years after diagnosis after her initial plan changed from lumpectomy, chemotherapy, and radiation therapy to immunotherapy and pain medication.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Emilcen's Patient Story

Patient Info: Emilcen, Female, 50s | Stage III

Emilcen was still receiving treatment for Stage III breast cancer more than 3 years after diagnosis, after mastectomy, chemotherapy, radiation therapy, and immunotherapy.

Our Cancer StoriesRead more →

Stage II Invasive Lobular Carcinoma: Alma's Patient Story

Patient Info: Alma, Female | Stage II

Alma had Stage II invasive lobular carcinoma treated with lumpectomy, chemotherapy, radiation, and planned 10 years of tamoxifen, then found a local recurrence 4.5 years after diagnosis.

Lobular Breast Cancer AllianceRead more →

Stage II HR-Positive Invasive Lobular Carcinoma: Tanya's Patient Story

Patient Info: Tanya, Female, 40s | Stage II

Biomarkers: Genetic testing negative; Oncotype DX score 27; MammaPrint low risk; ER-positive

Tanya had Stage II ER-positive breast cancer with a large lobular tumor found on MRI, underwent bilateral mastectomy with immediate reconstruction, completed 4 rounds of chemotherapy, and started tamoxifen.

Lobular Breast Cancer AllianceRead more →

Stage IV Invasive Lobular Carcinoma: Katie's Patient Story

Patient Info: Katie, Female, 50s | Stage IV

Metastatic Site: Stomach | Pelvis | Spine

Katie was living with metastatic ILC involving the stomach wall, pelvis, and spine while taking ribociclib (Kisqali) with letrozole, with improved stomach findings and stable spine metastases after 6 rounds.

Lobular Breast Cancer AllianceRead more →

Stage IV Invasive Lobular Carcinoma: Beth's Patient Story

Patient Info: Beth, Female, 60s | Stage IV

Metastatic Site: Bone

Beth first received chemotherapy and hormone therapy for Stage II pleomorphic ILC in 2005, then developed bone metastases 16 years later and continued living actively with metastatic disease, including a later progression.

Lobular Breast Cancer AllianceRead more →

Stage III Invasive Lobular Carcinoma: Lucy's Survivor Story

Patient Info: Lucy, Female, 40s | Stage III

Lucy was treated for Stage III invasive lobular carcinoma with double mastectomy, aggressive chemotherapy, and radiation, and later celebrated 20 years with no evidence of disease.

Lobular Breast Cancer AllianceRead more →

Stage I Breast Cancer: Dianne's Survivor Story

Patient Info: Dianne Austin, Female, 40s | Stage I

Disease-free after treatment for early Stage I breast cancer, with chemotherapy and radiation completed and ongoing survivorship focused on resilience, hair loss recovery, and advocacy for better wig access for women of color.

Massachusetts General HospitalRead more →

Stage I Breast Cancer: Kevin's Patient Story

Patient Info: Kevin Jarvis, Male | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

Early male breast cancer treated with mastectomy, sentinel node biopsy, EC chemotherapy, paclitaxel/Taxol, and ongoing daily tamoxifen; latest source text describes good spirits and continued discussion of risk-reducing surgery, but does not explicitly state NED.

Stage IV HR-Positive Breast Cancer: Robbie's Patient Story

Patient Info: Robbie, Female | Stage IV

Biomarkers: Estrogen receptor-positive / ER-positive

Metastatic Site: Bone; liver

Living with metastatic breast cancer involving bone and liver after earlier DCIS and Stage II ER-positive breast cancer; ongoing treatment at Mass General focused on stabilization and long-term disease management.

Massachusetts General HospitalRead more →

How Learning To Ask For Help Can Make Life With MBC Easier

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: Not explicitly reported; HER2-targeted treatment with Herceptin and Tykerb reported

Metastatic Site: Brain; liver

Living with Stage IV metastatic breast cancer involving brain and liver; latest scans showed no evidence of disease, and she reported spending most of her Stage IV life in NED status.

breastcancer.orgRead more →

Breast Cancer: Genevieve's Survivor Story

Patient Info: Genevieve, Female, 40s

Biomarkers: 1987 tumor not hormone-receptive; 2017 tumor hormone-receptive. 2022 full marker panel not stated.

After breast cancer episodes beginning in 1987, another tumor in 2017, and cancer found again in 2022, PET scans every 3-4 months were clear and she described herself as in remission again as of May 2025.

breastcancer.orgRead more →

Stage II Invasive Ductal Carcinoma: Roxanne's Survivor Story

Patient Info: Roxanne, Female, Under 40 | Stage II

Biomarkers: Genetic testing reported no hereditary/family-risk finding; tumor biomarker status not reported

Completed chemotherapy, surgery, and radiation for Stage IIB invasive ductal carcinoma; the source title identifies no evidence of disease after treatment, and she described herself as a survivor after finishing treatment on 28 April 2025.

breastcancer.orgRead more →

Faith And Humility: Stage I Breast Cancer treatment and follow-up story

Patient Info: Anonymized, Female | Stage I

Completed surgery, chemotherapy, and radiotherapy for early breast cancer about 9 months before the story and was living in recovery; no explicit NED/cancer-free status is stated.

breastcancer.orgRead more →

Stage III Breast Cancer: Cher's Survivor Story

Patient Info: Cher, Female | Stage III

Biomarkers: Hormone-positive; HER2-negative; Oncotype DX score 0

No evidence of disease after treatment for Stage IIIB breast cancer, with ongoing adjuvant Verzenio, long-term hormone blockers, and planned preventive mastectomy/DIEP flap reconstruction.

breastcancer.orgRead more →

Triple-Negative Breast Cancer: Valerie's Survivor Story

Patient Info: Valerie Hamilton, Female, 50s | Stage Metastatic/Advanced

Biomarkers: Triple-negative breast cancer; ER-negative; PR-negative; HER2-negative

Valerie completed chemotherapy, lumpectomy and radiation for locally advanced triple-negative breast cancer and preserved her breast/body image; no explicit NED or cancer-free status was provided.

Memorial Sloan KetteringRead more →

Stage II HR-Positive Invasive Lobular Carcinoma: Eutha's Survivor Story

Patient Info: Eutha, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

Eutha completed clinical-trial immunotherapy, right mastectomy with lymph-node removal, chemotherapy, radiation and reconstruction for Stage II ER-positive, PR-positive, HER2-positive breast cancer, and returned to work and community life; no explicit NED/cancer-free status was provided.

Memorial Sloan KetteringRead more →

Stage I Breast Cancer: Rosanna's Survivor Story

Patient Info: Rosanna Silber, Female, Under 40 | Stage I

Rosanna had no evidence of cancer after treatment for Stage I breast cancer and later cervical cancer, with ongoing checkups every 6 months for cervical cancer and annually for breast cancer.

Memorial Sloan KetteringRead more →

Stage II Breast Cancer: Nicole's Survivor Story

Patient Info: Nicole Grogan, Female, 40s | Stage II

Nicole completed surgery, chemotherapy, radiation and the exercise trial, and had no evidence of disease at her July 2019 appointment.

Memorial Sloan KetteringRead more →

HER2-Positive Breast Cancer: Jim's Patient Story

Patient Info: Jim Keegan, Male, 70+

Biomarkers: HER2-positive; BRCA1/BRCA2 negative

Jim completed surgery, chemotherapy and 1 year of Herceptin for early-stage HER2-positive male breast cancer, then continued tamoxifen and yearly MSK surveillance while advocating for male breast cancer awareness.

Memorial Sloan KetteringRead more →

Stage I Breast Cancer: Michelle's Survivor Story

Patient Info: Michelle Kang, Female, Under 40 | Stage I

Biomarkers: Hormone-positive breast cancer; no suspicious inherited genetic mutation reported

Michelle was 6 years cancer-free after Stage 1B hormone-positive breast cancer while continuing hormone therapy, Zometa, Signatera blood testing, reconstruction follow-up, and survivorship monitoring.

City of HopeRead more →